Holly B. Windham - 18 Mar 2026 Form 3 Insider Report for Cellebrite DI Ltd. (CLBT)

Reporting relationship: General Counsel & Chief Compliance Officer
Issuer ticker: CLBT
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 08:16:15 UTC
Prior SEC filing: 17 Nov 2022
Source filing: View source filing
Reporting owner signature: /s/ Holly Windham

Key filing fact

Holly B. Windham filed Form 3 for Cellebrite DI Ltd. (CLBT) on 18 Mar 2026.

Key facts

This page summarizes Holly B. Windham's Form 3 filing for Cellebrite DI Ltd. (CLBT).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 08:16.

Change

Previous filing in this sequence was filed on 17 Nov 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001815199 Primary reporting owner

Windham Holly B.

Relationship: General Counsel & Chief Compliance Officer
Address: 94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
Signature: /s/ Holly Windham
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBT holding

Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 95,328
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 47,938 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on November 5, 2025 and vest as follows: 11,986 vest on the first anniversary of the grant date and 2,996 vest every three months thereafter through November 5, 2029. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Footnote F2

Includes 47,390 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 11,858 vest on the first anniversary of the grant date and 2,961 vest every three months thereafter through February 10, 2030.

SEC remarks

General Counsel & Chief Compliance Officer